PubRank

R Buhl

Author PubWeight™ 103.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [German guideline for diagnosis and management of idiopathic pulmonary fibrosis]. Pneumologie 2013 3.03
2 The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001 2.77
3 Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007 1.99
4 Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med 2003 1.97
5 Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol (1985) 1993 1.88
6 Nasal CPAP therapy: effects of different CPAP levels on pressure transmission into the trachea and pulmonary oxygen transfer. Acta Anaesthesiol Scand 2002 1.76
7 Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 2007 1.64
8 The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 2005 1.51
9 Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis 1991 1.49
10 The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 1994 1.42
11 [Guideline-adherent treatment for asthma]. Internist (Berl) 2008 1.40
12 [Combination of asthma and COPD: more frequent as considered to be?]. Pneumologie 2006 1.40
13 [beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League]. Dtsch Med Wochenschr 2007 1.39
14 Safety and tolerability of omalizumab. Clin Exp Allergy 2009 1.26
15 [Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin]. Pneumologie 2007 1.23
16 Effect of internal thoracic artery preparation on blood loss, lung function, and pain. Ann Thorac Surg 1999 1.18
17 Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals. Eur Respir J 2000 1.17
18 Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001 1.16
19 Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur Respir J 2007 1.16
20 Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J 2007 1.13
21 Malignant peripheral nerve sheath tumours--report of 8 cases and review of the literature. Acta Neurochir (Wien) 2001 1.13
22 Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien) 2000 1.12
23 Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. Respiration 2003 1.10
24 Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany. Respir Med 2009 1.09
25 Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991 1.07
26 Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. J Clin Invest 1991 1.06
27 [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Pneumologie 2006 1.05
28 Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol 2001 1.04
29 Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Eur Respir J 1998 1.03
30 Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol (1985) 1993 1.02
31 Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium. J Appl Physiol (1985) 1990 1.00
32 Stroke pattern interpretation: the variability of hypertensive versus amyloid angiopathy hemorrhage. Cerebrovasc Dis 2001 0.98
33 Glutathione in induced sputum of healthy individuals and patients with asthma. Thorax 2001 0.97
34 Measuring asthma control: a comparison of three classification systems. Eur Respir J 2010 0.96
35 Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest 2001 0.96
36 Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 1995 0.96
37 Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur Respir J 2002 0.95
38 Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant 2001 0.93
39 Surgical treatment of septic deep venous thrombosis. Surgery 1995 0.93
40 Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol (1985) 1999 0.93
41 Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage. J Zhejiang Univ Sci 2004 0.93
42 Recommendations for management of equine athletes with cardiovascular abnormalities. J Vet Intern Med 2014 0.92
43 Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr 2002 0.90
44 [Guidelines for the diagnosis and treatment chronic obstructive bronchitis and pulmonary emphysema issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für pneumologie]. Pneumologie 2002 0.90
45 Effect of different asthma treatments on risk of cold-related exacerbations. Eur Respir J 2011 0.89
46 Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma. Allergy 2008 0.88
47 Unusual locations for cavernous hemangiomas: report of two cases and review of the literature. Acta Neurochir (Wien) 2005 0.88
48 A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy 2003 0.87
49 Stability of glutathione in induced sputum: impact of freezing. Respiration 2003 0.86
50 c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis. Int J Cancer 2001 0.86
51 Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis. J Cyst Fibros 2004 0.86
52 Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: real-life data. Respir Med 2010 0.86
53 The effects of prostacyclin on gastric intramucosal pH in patients with septic shock. Intensive Care Med 1995 0.85
54 Indoor air pollutants stimulate interleukin-8-specific mRNA expression and protein secretion of alveolar macrophages. Lung 1999 0.85
55 Soot-exposed mononuclear cells increase inflammatory cytokine mRNA expression and protein secretion in cocultured bronchial epithelial cells. Respiration 2000 0.84
56 Lymphocyte transformation test in a group of foundry workers exposed to beryllium and non-exposed controls. Eur J Respir Dis Suppl 1986 0.84
57 Tumor necrosis factor-alpha modulates the selective interference of hypnotics and sedatives to suppress N-formyl-methionyl-leucyl-phenylalanine-induced oxidative burst formation in neutrophils. Crit Care Med 1997 0.84
58 Clinical outcome after surgery of intracranial unruptured aneurysms: results of a series between 1991 and 2001. Acta Neurochir Suppl 2002 0.83
59 Short-term effects of regular salmeterol treatment on adult cystic fibrosis patients. Eur Respir J 1997 0.83
60 Kalanchoe pinnata inhibits mast cell activation and prevents allergic airway disease. Phytomedicine 2011 0.83
61 Jugular venous pooling during lowering of the head affects blood pressure of the anesthetized giraffe. Am J Physiol Regul Integr Comp Physiol 2009 0.83
62 Prevalence of exercise-associated arrhythmias in normal performing dressage horses. Equine Vet J Suppl 2010 0.83
63 Glutathione in spermatozoa and seminal plasma of infertile men. Hum Reprod 1998 0.82
64 Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress. Eur Respir J 1997 0.82
65 Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2007 0.81
66 Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity. Chest 1996 0.81
67 Controlled and uncontrolled allergic asthma in routine respiratory specialist care - a clinical-epidemiological study in Germany. Curr Med Res Opin 2011 0.80
68 Cigarette smoking, but not sensitization to Alternaria, is associated with severe asthma in urban patients. J Asthma 2001 0.80
69 Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. Thorax 1993 0.80
70 Nasal continuous positive airway pressure: A method to avoid endotracheal reintubation in postoperative high-risk patients with severe nonhypercapnic oxygenation failure. Chest 2000 0.80
71 Dural invasion of meningiomas adjacent to the tumor margin on Gd-DTPA-enhanced MR images: histopathologic correlation. Eur Radiol 1998 0.80
72 The whole story: treatment outcomes with Symbicort. Respir Med 2002 0.79
73 Comparing asthma treatment in elderly versus younger patients. Respir Med 2011 0.79
74 Additional NO2 exposure induces a decrease in cytokine specific mRNA expression and cytokine release of particle and fibre exposed human alveolar macrophages. Eur J Med Res 1999 0.78
75 Intermediate-term clinical and hemodynamic results of the neonatal arterial switch operation for complete transposition of the great arteries. Int J Cardiol 1992 0.78
76 Do barbiturates impair zymosan-induced granulocyte function? J Crit Care 1994 0.78
77 Statistical analysis of chronic obstructive pulmonary disease exacerbations in clinical studies: expectations and limitations. J Physiol Pharmacol 2009 0.78
78 Vertebral artery decompression in a patient with rotational occlusion. Acta Neurochir (Wien) 2008 0.78
79 Sputum induction leads to a decrease of exhaled nitric oxide unrelated to airflow. Eur Respir J 2003 0.78
80 [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?]. Dtsch Med Wochenschr 2008 0.78
81 Do barbiturates and their solutions suppress FMLP-induced neutrophil chemiluminescence? Eur J Anaesthesiol 1994 0.78
82 Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment. Allergy 2010 0.77
83 Opioids with different affinity for subreceptors induce different effects on early and late sensory evoked potentials (SEP) in man. NIDA Res Monogr 1986 0.77
84 [MR myelography in spinal canal stenosis]. Rofo 1997 0.77
85 Restoration of impaired cytokine secretion from monocytes of patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3. Leukemia 1993 0.77
86 Induced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung function. Thorax 2001 0.77
87 Intracranial cavernomas: indications for and results of surgery. Neurol Med Chir (Tokyo) 1998 0.77
88 [Does phenotyping asthma help to improve differential treatment?]. Dtsch Med Wochenschr 2010 0.77
89 Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients. Arzneimittelforschung 1993 0.76
90 [Pathogenesis of bronchial asthma--unveiling new therapeutic prospects]. Med Klin (Munich) 2001 0.76
91 [Recommendations for the choice of inhalatory systems for drug prescription]. Pneumologie 2001 0.76
92 Omalizumab versus 'usual care': results from a naturalistic longitudinal study in routine care. Int Arch Allergy Immunol 2012 0.76
93 [Treatment strategies for asthma]. Internist (Berl) 2012 0.76
94 [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma]. Pneumologie 2002 0.76
95 Glutathione deficiency and HIV. Lancet 1990 0.76
96 [Treatment of bronchial asthma using a new adjustable combination treatment plan: Asthma Control Plan (ATACO)]. Pneumologie 2001 0.76
97 Mediastinal lymph nodes demonstrated by mediastinal sonography: activity marker in patients with cystic fibrosis. J Clin Ultrasound 1999 0.76
98 Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients. Eur Respir J 1999 0.76
99 Asbestos-exposed blood monocytes--deoxyribonucleic acid strand lesions in co-cultured bronchial epithelial cells. Scand J Work Environ Health 2000 0.76
100 Detection of normal mediastinal lymph nodes by ultrasonography. Acta Radiol 1997 0.76
101 Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses. J Vet Intern Med 2014 0.76
102 [Dura thickening adjacent to intracranial, para-dural space-occupying lesions in MRI. Histologic correlation]. Aktuelle Radiol 1997 0.75
103 Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. Eur Respir J 2010 0.75
104 [Specific immunotherapy for allergic asthma?]. Pneumologie 2003 0.75
105 The value of preoperative chest X-rays in gynecological patients. Arch Gynecol Obstet 1988 0.75
106 [Correlation of plasma glutathione and total IgE level: evidence for a regulatory role of antipxodants in vivo]. Pneumologie 2000 0.75
107 [The German severe asthma registry]. Pneumologie 2012 0.75
108 [Hemorrhagic pericardial effusion and multiple pulmonary nodules in a 37 year old male who has "never smoked"]. Internist (Berl) 2009 0.75
109 Demonstration of pulmonary beta2-adrenergic receptor binding in vivo with [18F]fluoroethyl-fenoterol in a guinea pig model. Eur J Nucl Med Mol Imaging 2005 0.75
110 [Strategies for gene therapy in cystic fibrosis]. Pneumologie 1996 0.75
111 [Asthma: new insights and advances in treatment]. Dtsch Med Wochenschr 2011 0.75
112 [Effectiveness and tolerance of a combination of fluticasone and salmeterol in patients with obstructive airway diseases. DUO Study Group]. Pneumologie 1998 0.75
113 [Treatment of small airway diseases--today and tomorrow]. Pneumologie 2009 0.75
114 Modulation of cystic fibrosis transmembrane conductance regulator gene - expression by elevation of intracellular cyclic AMP. Eur J Med Res 1998 0.75
115 [Solid combination of budesonide and formoterol in the treatment of bronchial asthma]. Pneumologie 2001 0.75
116 [Antioxidative treatment of idiopathic pulmonary fibrosis]. Pneumologie 2006 0.75
117 [Paraneoplastic limbic encephalitis in small cell lung carcinoma]. Pneumologie 2004 0.75
118 [Immunopathogenesis of extrinsic allergic alveolitis]. Immun Infekt 1995 0.75
119 ['95 pneumology update. Progress and perspectives in pneumology. Paradigms of change (II)]. Med Klin (Munich) 1995 0.75
120 [Clinical significance of gastrooesophageal reflux in asthma]. Pneumologie 2006 0.75
121 [Inhalable corticosteroids in long-term COPD treatment. Opinions of an expert panel]. Pneumologie 2000 0.75
122 [Transcutaneous nerve stimulation in migraine patients. Preliminary results]. Fortschr Med 1985 0.75
123 Unspecific bronchial reactivity to carbachol in healthy subjects--effect of age and smoking habits. Respiration 1994 0.75
124 Effects of 5 mg sublingual nitrendipine in patients with precapillary pulmonary hypertension due to pulmonary fibrosis. J Cardiovasc Pharmacol 1988 0.75
125 [Effectiveness of supportive psychotherapy in hospitalized patients: empirical findings and practice-related consequences]. Psychother Psychosom Med Psychol 1985 0.75
126 [Lung compliance in man is impaired by the rapid injection of alfentanyl]. Anaesthesist 1986 0.75
127 [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)]. Pneumologie 2003 0.75
128 [The path from the pediatrician to the internist]. Pneumologie 1996 0.75
129 [Alfentanil as the last dose (on top) in neuroleptanesthesia with fentanyl. Pharmacokinetics and pharmacodynamics with reference to the cortical effect]. Anaesthesist 1986 0.75
130 Somatosensory-evoked potentials (SEPs) are affected differently by mu- and kappa-selective opioids in the dog. Funct Neurol 1988 0.75
131 [Trial end-point in chronic obstructive pulmonary disease (COPD): minimal clinically important difference]. Pneumologie 2008 0.75
132 [Regulation of glutathione level in venous plasma and aqueous humor in cataracta senilis provecta]. Ophthalmologe 1996 0.75
133 [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin]. Pneumologie 1998 0.75
134 Longterm efficiency of high dose inotropic support in an infant after repair of Fallot's tetralogy. J Cardiovasc Surg (Torino) 1996 0.75
135 [Therapy of cystic fibrosis in adulthood--current and future management]. Pneumologie 1995 0.75
136 Spirometric gated quantitative computed tomography of the lung in healthy smokers and nonsmokers. Invest Radiol 1997 0.75
137 Metastatic meningioma WHO grade II of the cervical spine: case report and review of the literature. Zentralbl Neurochir 2005 0.75
138 [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma]. Pneumologie 2010 0.75
139 [Cost effectiveness of BDP/formoterol fixed vs. two single inhalers in the treatment of bronchial asthma]. MMW Fortschr Med 2010 0.75
140 Pseudotumour cerebri and optic hydrops--magnetic resonance imaging diagnostic and therapeutical considerations in a paediatric case. Eur J Radiol 1998 0.75
141 Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer. Respiration 2003 0.75
142 [efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases]. Pneumologie 2000 0.75
143 [Current assessment of physician manpower needs in surgery]. Chirurg 1998 0.75
144 [Bulimia with and without a history of anorexia--variants or entities?]. Psychother Psychosom Med Psychol 1990 0.75
145 [Onset of action of formoterol in patients with moderate to severe, partially reversible airflow obstruction assessed by bodyplethysmography]. Pneumologie 2002 0.75
146 [Epidemiology of tuberculosis in patients with HIV infection of the Frankfurt University Clinic]. Med Klin (Munich) 1993 0.75
147 [Clinical trial endpoints in alpha-1-antitrypsin deficiency: interdisciplinary aspects]. Pneumologie 2011 0.75
148 [Benign fibro-osseous tumors of the frontal skull base with intracranial extension. Report of 2 cases]. HNO 2004 0.75
149 [Bronchial asthma versus chronic obstructive lung disease (COPD). From pathogenesis to differential diagnosis and differential therapy]. Dtsch Med Wochenschr 2005 0.75
150 [Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE)]. Pneumologie 2004 0.75
151 [Measuring airway inflammation in clinical practise - application and interpretation]. Pneumologie 2007 0.75
152 [Difficult to manage asthma: clinical phenotypes and principles of therapy]. Pneumologie 2002 0.75
153 [Therapy of lung diseases with antiproteases]. Pneumologie 1994 0.75
154 [Therapy of lung cancer]. Pneumologie 2005 0.75
155 [Anticholinergic drugs in therapy of chronic obstructive lung disease (COPD)]. Med Klin (Munich) 2000 0.75
156 [Management of acute exacerbation of chronic obstructive pulmonary disease (COPD)]. Dtsch Med Wochenschr 2003 0.75
157 [First antibody against IgE in view. Hope for severely ill asthmatic patients ]. MMW Fortschr Med 2005 0.75
158 [Gene therapy in cancers of the lung and pleura]. Pneumologie 1999 0.75
159 [Clinical aspects and diagnosis of chronic berylliosis--a case report]. Pneumologie 1990 0.75
160 ['95 pneumology update. Progress and prospects in pneumology. Paradigm of change--II]. Med Klin (Munich) 1996 0.75